In this webinar, join Marcia Richards Suelzer, Senior Manager, Strategy & Planning, CT Corporation, Wolters Kluwer to:

• Become aware of revisions made to Behavioral Health Services (§483.40) and Pharmacy Services (§483.45).
• Become familiar with rules contained in §483.45(e), Psychotropic medications, including:
  • Classes of medication targeted
  • Mandates for gradual dose reduction
  • Restrictions on PRN orders for these medications
• Become aware of increased need for documentation regarding appropriate use of psychotropic medications

Link to PDF Slides: Psychotropic Medication Considerations Under Revised 42-483-45